Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)
January 19 2021 - 4:21PM
Edgar (US Regulatory)
Filed Pursuant to Rule 433
Issuer Free Writing Prospectus
dated
January 19, 2021
Registration No. 333-237278
Supplementing the Preliminary
Prospectus Supplement dated January 19, 2021
and Prospectus dated January 19, 2021
National Health Investors, Inc.
PRICING TERM SHEET
|
|
|
Issuer:
|
|
National Health Investors, Inc. (the Issuer)
|
|
|
Guarantors:
|
|
Certain of the Issuers direct and indirect subsidiaries as described in the Preliminary Prospectus Supplement referred to above (the Guarantors)
|
|
|
Security:
|
|
3.000% Senior Notes due 2031 (the Notes)
|
|
|
Ranking:
|
|
Senior Unsecured
|
|
|
Format:
|
|
SEC Registered
|
|
|
Expected Ratings*:
|
|
Baa3 (Moodys) / BBB- (S&P) / BBB- (Fitch)
|
|
|
Trade Date:
|
|
January 19, 2021
|
|
|
Settlement Date:
|
|
January 26, 2021 (T+5)
|
|
|
Use of Proceeds:
|
|
The Issuer expects to use the net proceeds from this offering to repay its $100 million senior unsecured term loan facility, which matures in July 2021, and to reduce borrowings outstanding under its $550 million senior
unsecured revolving credit facility with any remaining amounts being used for general corporate purposes, including the repayment of short-term and long-term debt.
|
|
|
Principal Amount:
|
|
$400,000,000
|
|
|
Benchmark Treasury:
|
|
UST 0.875% due November 15, 2030
|
|
|
Benchmark Treasury Yield:
|
|
1.094%
|
|
|
Spread to Benchmark Treasury:
|
|
+200 bps
|
|
|
Yield to Maturity:
|
|
3.094%
|
|
|
Price to Public:
|
|
99.196% of principal amount of the Notes, plus accrued interest, if any, from January 26, 2021
|
|
|
Coupon (Interest Rate):
|
|
3.000% per annum
|
|
|
Gross Proceeds to the Issuer:
|
|
$396,784,000
|
|
|
Interest Payment Dates:
|
|
February 1 and August 1, commencing August 1, 2021
|
|
|
Maturity Date:
|
|
February 1, 2031
|
|
|
Record Dates:
|
|
January 15 and July 15
|
|
|
|
Optional Redemption Provisions:
|
|
|
|
|
Make-Whole Call:
|
|
Prior to November 1, 2030, T+30 basis points
|
|
|
Par Call:
|
|
On or after November 1, 2030
|
|
|
CUSIP / ISIN:
|
|
63633D AF1/US63633DAF15
|
|
|
Denominations/Multiple:
|
|
$2,000 / $1,000
|
|
|
Joint Book-Running Managers:
|
|
Wells Fargo Securities, LLC
BofA Securities,
Inc.
KeyBanc Capital Markets Inc.
BMO Capital Markets
Corp.
Goldman Sachs & Co. LLC
J.P. Morgan Securities
LLC
|
|
|
Senior Co-Manager:
|
|
Capital One Securities, Inc.
|
|
|
Co-Managers:
|
|
Hancock Whitney Investment Services, Inc.
RBC
Capital Markets, LLC
Regions Securities LLC
Stifel,
Nicolaus & Company, Incorporated
|
*
|
Note: A security rating is not a recommendation to buy, sell or hold securities, and may be subject to
revision or withdrawal at any time. Each of the security ratings above should be evaluated independently of any other security rating.
|
The Issuer and the Guarantors have filed a registration statement (including a prospectus dated January 19, 2021 and a preliminary prospectus
supplement dated January 19, 2021) with the SEC for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement, the related preliminary prospectus supplement and other
documents the Issuer has filed with the SEC for more complete information about the Issuer, the Guarantors and this offering. You may obtain these documents for free by visiting EDGAR on the SEC web site at www.sec.gov. Alternatively, the Issuer,
any underwriter or any dealer participating in the offering will arrange to send you the prospectus and preliminary prospectus supplement if you request it by calling Wells Fargo Securities, LLC toll-free at (800)
645-3751 or wfscustomerservice@wellsfargo.com, or BofA Securities, Inc. toll-free at (800) 294-1322 or KeyBanc Capital Markets Inc. toll-free at (866) 227-6479.
National Health Investors (NYSE:NHI)
Historical Stock Chart
From Apr 2024 to May 2024
National Health Investors (NYSE:NHI)
Historical Stock Chart
From May 2023 to May 2024